Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Shaffer

Showing results (101-110 of 176) with videos related to

Pageof 18
Sort By:
Blood Advances|July 6, 2022
Improved GRFS after posttransplant cyclophosphamide-based vs ATG-based HLA-mismatched unrelated donor transplantAntonio Jimenez Jimenez, Krishna Komanduri, Samantha Brown, et al.
BMC Psychology|April 24, 2025
Study protocol for a randomized controlled trial of Regulating Together (RT), a group therapy for emotion dysregulation in school-age autistic youth and their caregiversWalker S McKinney, Lauren J Tadevich, Lauren M Schmitt, et al.
Research Square|May 10, 2023
Empirical Frequency Bound Derivation Reveals Prominent Mid-Frontal Alpha Associated with Neurosensory Dysfunction in Fragile X SyndromeErnest V Pedapati, John A Sweeney, Lauren M Schmitt, et al.
Blood Advances|May 17, 2023
Emergence of human CMV-induced NKG2C+ NK cells is associated with CD8+ T-cell recovery after allogeneic HCTKattria van der Ploeg, Rosa Sottile, Theodota Kontopoulos, et al.
Journal of Autism and Developmental Disorders|November 23, 2024
Parent-Reported Outcome Measures for Individuals with Fragile X Syndrome: Clinically Meaningful Change ThresholdsMeredith A Nelson, Lauren M Schmitt, Paul S Horn, et al.
Blood Advances|February 24, 2023
Lenalidomide-associated B-cell ALL: clinical and pathologic correlates and sensitivity to lenalidomide withdrawalMark B Geyer, Brian C Shaffer, Bhavana Bhatnagar, et al.
Journal of Autism and Developmental Disorders|August 31, 2019
Pharmacologic Interventions for Irritability, Aggression, Agitation and Self-Injurious Behavior in Fragile X Syndrome: An Initial Cross-Sectional AnalysisEleanor M Eckert, Kelli C Dominick, Ernest V Pedapati, et al.
Blood Advances|April 12, 2021
Prospective KIR genotype evaluation of hematopoietic cell donors is feasible with potential to benefit patients with AMLBrian C Shaffer, Jean-Benoit Le Luduec, Soo Park, et al.
Blood Advances|March 1, 2024
Racial/ethnic disparities in availability of volunteer unrelated donors for allogeneic transplantationWarren B Fingrut, Eric Davis, Anne Archer, et al.
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|March 13, 2024
What Can State Medical Boards Do to Effectively Address Serious Ethical Violations?Tristan McIntosh, Elizabeth Pendo, Heidi A Walsh, et al.
Pageof 18

Showing results (101-110 of 176) with videos related to

Sort By:
Pageof 18
Blood Advances|July 6, 2022
Improved GRFS after posttransplant cyclophosphamide-based vs ATG-based HLA-mismatched unrelated donor transplantAntonio Jimenez Jimenez, Krishna Komanduri, Samantha Brown, et al.
BMC Psychology|April 24, 2025
Study protocol for a randomized controlled trial of Regulating Together (RT), a group therapy for emotion dysregulation in school-age autistic youth and their caregiversWalker S McKinney, Lauren J Tadevich, Lauren M Schmitt, et al.
Research Square|May 10, 2023
Empirical Frequency Bound Derivation Reveals Prominent Mid-Frontal Alpha Associated with Neurosensory Dysfunction in Fragile X SyndromeErnest V Pedapati, John A Sweeney, Lauren M Schmitt, et al.
Blood Advances|May 17, 2023
Emergence of human CMV-induced NKG2C+ NK cells is associated with CD8+ T-cell recovery after allogeneic HCTKattria van der Ploeg, Rosa Sottile, Theodota Kontopoulos, et al.
Journal of Autism and Developmental Disorders|November 23, 2024
Parent-Reported Outcome Measures for Individuals with Fragile X Syndrome: Clinically Meaningful Change ThresholdsMeredith A Nelson, Lauren M Schmitt, Paul S Horn, et al.
Blood Advances|February 24, 2023
Lenalidomide-associated B-cell ALL: clinical and pathologic correlates and sensitivity to lenalidomide withdrawalMark B Geyer, Brian C Shaffer, Bhavana Bhatnagar, et al.
Journal of Autism and Developmental Disorders|August 31, 2019
Pharmacologic Interventions for Irritability, Aggression, Agitation and Self-Injurious Behavior in Fragile X Syndrome: An Initial Cross-Sectional AnalysisEleanor M Eckert, Kelli C Dominick, Ernest V Pedapati, et al.
Blood Advances|April 12, 2021
Prospective KIR genotype evaluation of hematopoietic cell donors is feasible with potential to benefit patients with AMLBrian C Shaffer, Jean-Benoit Le Luduec, Soo Park, et al.
Blood Advances|March 1, 2024
Racial/ethnic disparities in availability of volunteer unrelated donors for allogeneic transplantationWarren B Fingrut, Eric Davis, Anne Archer, et al.
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|March 13, 2024
What Can State Medical Boards Do to Effectively Address Serious Ethical Violations?Tristan McIntosh, Elizabeth Pendo, Heidi A Walsh, et al.
Pageof 18